1. Evolving strategies in the treatment of childhood rhabdomyosarcoma : Slovenian experienceŽiva Pohar-Marinšek, Jožica Anžič, Berta Jereb, 2001, izvirni znanstveni članek Povzetek: Background. Neoadjuvant chemotherapy (Cht) has changed the treatment of rhabdomyosarcoma (RMS) in children. The purpose of our study was to review thechildren treated for RMS between 1974 and 1996. Patients and methods. Fifty-one children, 1-15 years old, were included. Primary sites of tumour were: head and neck 15, orbit 6, genitourinary 12, extremity 9, torso 5 and paratesticular 4. Twelve patients were in stage 1, 10 in stage II, 26 in stage111 and 3 in stage IV. Of 43 histologically confirmed RMS 25 were embryonal, 13 alveolar, 1 botryoid, 1 spindle cell and 3 sarcoma NOS. In 8 patients, only fine needle aspiration biopsy (FNAB) was available. All patients had Cht, 29 neoadjuvant, 20 had surgery first, 40 had irradiation (RT), 2 stage IV patients had bone marrow transplant (ABMT). Multidrug Cht varied: VCR, AMD, and cyclophosphamide (VAC) were used in the 1970s, with Adriablastine (T2), methotrexat (MTX) and/or other drugs (T6, T11) in the 1980s; and in the 1990s, cyclophosphamide was replaced by ifosfamide (VAIA). The treatment was started with Cht in orbital and head and neck tumours and inthe majority of genitourinary tumours, but surgery was first in paratesticular and in the majority of extremity tumours. Results. The 3 patients with stage IV disease died. Of those with localised tumour, 34 (70%) were alive and well 5 years after treatment, 80% stage I, 75% stage II and 61%stage III. One patient died of heart failure, 3 of Cht toxicity and 1 of intereurrent disease. Conclusions. (Abstract truncated at 2000 characters)
Objavljeno v DiRROS: 26.01.2024; Ogledov: 128; Prenosov: 29
 Celotno besedilo (177,30 KB) |
2. Resections of pelvic bone and sacrum, Ljubljana experienceJanez Novak, Marjana Čuček-Pleničar, Darja Eržen, Franc Srakar, Mojca Senčar, Boštjan Baebler, Jožica Červek, Alenka Vodnik-Cerar, Matej Bračko, Živa Pohar-Marinšek, Jožica Anžič, 1997, izvirni znanstveni članek Objavljeno v DiRROS: 16.01.2024; Ogledov: 181; Prenosov: 41
Celotno besedilo (156,79 KB) |
3. Navodila ginekologom za delo v programu ZORA : posodobitev 2011Maja Primic-Žakelj, Marjetka Uršič-Vrščaj, Ana Pogačnik, Urška Ivanuš, Andrej Možina, Živa Pohar-Marinšek, Mario Poljak, 2011, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid Ključne besede: citodiagnostika, presejanje, papiloma virusi, kolposkopija, predrakave spremembe, diagnostika, zdravljenje, zborniki
Objavljeno v DiRROS: 04.06.2020; Ogledov: 1719; Prenosov: 611
Celotno besedilo (4,75 MB) |
4. Navodila za poenotenje izvidov brisov materničnega vratuAna Pogačnik, Irena Srebotnik-Kirbiš, Alenka Repše-Fokter, Živa Pohar-Marinšek, Vivijana Snoj, Irena Kirar-Fazarinc, Maja Primic-Žakelj, 2005, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid Ključne besede: bris, citopatologija
Objavljeno v DiRROS: 04.06.2020; Ogledov: 1787; Prenosov: 523
Celotno besedilo (1,15 MB) |
5. Smernice diagnostike in zdravljenja diferenciranega raka ščitniceNikola Bešić, Andreja A. Schwarzbartl-Pevec, Andreja Klevišar Ivančič, Barbara Vidergar-Kralj, Barbara Gazić, Blaž Krhin, Branko Zakotnik, Cvetka Grašič-Kuhar, Damijan Bergant, Edvard Pirnat, Helena Gutnik, Ivana Žagar, Jerca Blazina, Katja Zaletel, Margareta Strojan Fležar, Marko Hočevar, Marta Dremelj, Nebojša Glumac, Olga Blatnik, Simona Gaberšček, Snežana Pavlović Djokić, Ulrika Klopčič, Veronika Kloboves-Prevodnik, Živa Pohar-Marinšek, 2017, slovar, enciklopedija, leksikon, priročnik, atlas, zemljevid Ključne besede: rak ščitnice, diferencirani rak, zdravljenje, smernice
Objavljeno v DiRROS: 27.05.2020; Ogledov: 1900; Prenosov: 618
Celotno besedilo (712,25 KB) |
6. |
7. Atipične žlezne celice, neopredeljene : rezultati revizije citoloških preparatov in tveganje CIN2+Veronika Kloboves-Prevodnik, Simona Uhan Kastelic, Živa Pohar-Marinšek, Tina Žagar, Urška Ivanuš, 2014, objavljeni znanstveni prispevek na konferenci Ključne besede: bris materničnega vratu, atipične žlezne celice, lezije
Objavljeno v DiRROS: 08.04.2020; Ogledov: 2284; Prenosov: 645
Celotno besedilo (167,95 KB) |
8. |
9. |
10. Paragangliom kot zasevek : primer bolnika s paragangliomom in rakom na modihBarbara Perić, Živa Pohar-Marinšek, Breda Škrbinc, Maja Marolt-Mušič, Ivana Žagar, Marko Hočevar, 2012, kratki znanstveni prispevek Ključne besede: paragangliomi, rak na modih, novotvorbe na modih
Objavljeno v DiRROS: 31.08.2018; Ogledov: 2946; Prenosov: 813
Celotno besedilo (831,40 KB) |
